ESTABLISHEDGOVERNMENTscience-backed 96%
Gene Editing And Agricultural Biotechnology Innovations
Quality 81/10047 signals5 source typessince 2026-05-13
History
Flagged 2026-05-13 · Status ESTABLISHED (since 2026-06-06) · last active 2026-07-28
2026-05-14signals (cumulative): 8 → 472026-07-28
Y = cumulative signals, X = time. A steep climb means the cluster is actively growing; a flat or abruptly-ending line means momentum is gone.
| date | signals | new | substance |
|---|---|---|---|
| 2026-05-14 | 8 | 75% | |
| 2026-05-20 | 8 | +0 | 75% |
| 2026-05-26 | 10 | +2 | 80% |
| 2026-05-31 | 10 | +0 | 80% |
| 2026-06-06 | 16 | +6 | 88% |
| 2026-06-12 | 18 | +2 | 89% |
| 2026-06-18 | 20 | +2 | 90% |
| 2026-06-23 | 23 | +3 | 91% |
| 2026-06-29 | 24 | +1 | 92% |
| 2026-07-05 | 32 | +8 | 94% |
| 2026-07-11 | 37 | +5 | 95% |
| 2026-07-16 | 41 | +4 | 95% |
| 2026-07-22 | 44 | +3 | 95% |
| 2026-07-28 | 47 | +3 | 96% |
Evidence
The 47 collected signals behind this trend — the 20 most recent, each linking to its primary source.
- 2026-07-24EPO Patents[EPO] SMALL NUCLEAR RIBONUCLEOPROTEIN 13 POLYPEPTIDES, POLYNUCLEOTIDES, AND USES THEREOF · detail
- 2026-07-24EPO Patents[EPO] METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES · detail
- 2026-07-24PubMedRethinking governance of synthetic cells. · detail
- 2026-07-17EPO Patents[EPO] METHODS AND COMPOSITIONS FOR FIXED SAMPLE ANALYSIS · detail
- 2026-07-17EPO Patents[EPO] SYNTHETIC TRANSCRIPTION FACTORS · detail
- 2026-07-17EPO Patents[EPO] POLYPEPTIDES HAVING CARBONIC ANHYDRASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME · detail
- 2026-07-16PubMedClosing the implementation gap: a harmonised EU framework for synthetic nucleic acid screening and customer verification. · detail
- 2026-07-15EPO Patents[EPO] NUCLEIC ACID CONSTRUCT AND METHOD FOR PRODUCING CIRCULAR RNA · detail
- 2026-07-15EPO Patents[EPO] METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES · detail
- 2026-07-12PubMedLAMP-Based Two-DNA-Fragment Fusion and Its Application in Nucleic Acid Detection. · detail
- 2026-07-10EPO Patents[EPO] SYSTEMS AND METHODS FOR MODIFYING A POLYNUCLEOTIDE · detail
- 2026-07-10EPO Patents[EPO] DNA aptamer-enabled intraoperative surgical pathology · detail
- 2026-07-10EPO Patents[EPO] High purity RNA compositions and methods for preparation thereof · detail
- 2026-07-08PubMedThe evolution of the United States nucleic acid screening policies. · detail
- 2026-07-08Federal Register[Notice] Government Owned Invention Available for License: Generating Conditional and Reverse Conditional Loss-of-Function Alleles in Mouse Casq2 · detail
- 2026-07-03EPO Patents[EPO] METHODS AND KITS FOR DNA EDITING AND TREATING, AMELIORATING AND/OR PREVENTING CANCER · detail
- 2026-07-03EPO Patents[EPO] REPROGRAMMABLE FANZOR POLYNUCLEOTIDES AND USES THEREOF · detail
- 2026-07-03EPO Patents[EPO] CARBONIC ANHYDRASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME · detail
- 2026-07-03EPO Patents[EPO] DNA RECOMBINASE FUSIONS · detail
- 2026-07-02EPO Patents[EPO] CHO TRANSCRIPTION CONTROL ELEMENTS AND USES THEREOF · detail